Loading...

10x Genomics, Inc. Peer Comparison

Metric Value Ranking
Market Cap $1.4 Billion 5/6 GH
$5.6B
VCYT
$3.2B
TWST
$2.8B
BEAM
$2.4B
TXG
$1.4B
FATE
$142.4M
Gross Margin 70% 3/6 FATE
100%
GH
100%
TXG
70%
VCYT
68%
BEAM
62%
TWST
45%
Profit Margin -24% 2/6 VCYT
13%
TXG
-24%
TWST
-41%
GH
-56%
FATE
-100%
BEAM
-100%
EBITDA margin -16% 2/6 VCYT
10%
TXG
-16%
TWST
-43%
GH
-61%
BEAM
-639%
FATE
-1704%
Quarterly Revenue $151.7 Million 2/6 GH
$191.5M
TXG
$151.7M
VCYT
$115.9M
TWST
$84.7M
BEAM
$14.3M
FATE
$3.1M
Quarterly Earnings -$35.8 Million 3/6 VCYT
$15.2M
TWST
-$34.7M
TXG
-$35.8M
FATE
-$47.7M
BEAM
-$96.7M
GH
-$107.8M
Quarterly Free Cash Flow $17.8 Million 2/6 VCYT
$27.7M
TXG
$17.8M
FATE
-$29.9M
GH
-$55.3M
BEAM
-$89.7M
TWST
-$0
Trailing 4 Quarters Revenue $629.7 Million 2/6 GH
$692.3M
TXG
$629.7M
BEAM
$349.6M
VCYT
$327.1M
TWST
$313.0M
FATE
$13.4M
Trailing 4 Quarters Earnings -$182.6 Million 3/6 GH
$191.5M
TXG
$151.7M
VCYT
$115.9M
TWST
$84.7M
BEAM
$14.3M
FATE
$3.1M
Quarterly Earnings Growth 62% 2/6 VCYT
280%
TXG
62%
TWST
25%
BEAM
-1%
FATE
-6%
GH
-25%
Annual Earnings Growth 35% 3/6 VCYT
175%
BEAM
58%
TXG
35%
FATE
8%
TWST
4%
GH
-68%
Quarterly Revenue Growth -1% 5/6 FATE
58%
GH
34%
VCYT
28%
TWST
27%
TXG
-1%
BEAM
-17%
Annual Revenue Growth 6% 5/6 BEAM
351%
FATE
184%
GH
25%
TWST
21%
TXG
6%
VCYT
-3%
Cash On Hand $398.2 Million 2/6 GH
$688.4M
TXG
$398.2M
VCYT
$274.1M
BEAM
$230.2M
TWST
$226.3M
FATE
$37.9M
Short Term Debt $9.4 Million 3/6 TWST
$14.8M
BEAM
$12.9M
TXG
$9.4M
VCYT
$7.3M
FATE
$6.9M
GH
-$0
Long Term Debt $76.5 Million 4/6 GH
$1.3B
BEAM
$298.3M
FATE
$92.1M
TXG
$76.5M
TWST
$70.2M
VCYT
$12.4M
PE -1.00 2/6 VCYT
166.89
TXG
-1.00
FATE
-1.00
GH
-1.00
TWST
-1.00
BEAM
-1.00
PS 2.27 6/6 FATE
10.59
VCYT
9.71
TWST
8.81
GH
8.10
BEAM
6.77
TXG
2.27
PB 1.98 4/6 TWST
5.83
BEAM
2.99
VCYT
2.70
TXG
1.98
FATE
0.39
GH
0.00
PC 3.59 6/6 TWST
12.18
VCYT
11.58
BEAM
10.28
GH
8.15
FATE
3.76
TXG
3.59
Liabilities to Equity 0.30 3/6 BEAM
0.48
FATE
0.37
TXG
0.30
TWST
0.30
VCYT
0.08
GH
0.00
ROA -0.19 3/6 VCYT
1%
BEAM
-12%
TXG
-19%
GH
-33%
TWST
-34%
FATE
-38%
ROE -0.25 4/6 GH
853%
VCYT
2%
BEAM
-18%
TXG
-25%
TWST
-44%
FATE
-52%
Current Ratio 4.36 2/6 VCYT
12.88
TXG
4.36
TWST
4.34
FATE
3.73
BEAM
3.08
GH
0.96
Quick Ratio 1.85 5/6 VCYT
166.89
TXG
-1.00
FATE
-1.00
GH
-1.00
TWST
-1.00
BEAM
-1.00
Long Term Debt to Equity 0.11 4/6 BEAM}
0.38
FATE}
0.25
TWST}
0.15
TXG}
0.11
VCYT}
0.01
GH}
-21.83
Debt to Equity 0.12 4/6 FATE
0.27
BEAM
0.20
TWST
0.18
TXG
0.12
VCYT
0.02
GH
-21.83
Burn Rate 9.67 1/6 TXG
9.67
TWST
5.50
GH
4.30
BEAM
2.06
FATE
0.71
VCYT
-21.35
Cash to Cap 0.28 1/6 TXG
0.28
FATE
0.27
GH
0.12
BEAM
0.10
VCYT
0.09
TWST
0.08
CCR -0.50 5/6 VCYT
1.83
BEAM
0.93
FATE
0.63
GH
0.51
TXG
-0.50
TWST
EV to EBITDA -47.23 4/6 VCYT}
243.05
FATE}
-3.88
BEAM}
-25.20
TXG}
-47.23
GH}
-53.10
TWST}
-72.54
EV to Revenue 1.78 6/6 FATE
15.13
GH
9.00
VCYT
8.93
TWST
8.35
BEAM
6.57
TXG
1.78